Search images on Google      Product Monograph

Active Ingredients:

• ustekinumab, 45 MG/0.5 ML

DIN: 02544202

Dosage Form(s): SOLUTION

Route(s) of Administration: SUBCUTANEOUS

Description: SINGLE-USE VIAL

Schedule: Prescription

Company: AMGEN CANADA INC

ATC:

• L04 - IMMUNOSUPPRESSANTS (ATC, WHO, Wiki)
• L04A - IMMUNOSUPPRESSANTS (ATC, WHO)
• L04AC - Interleukin inhibitors (ATC, WHO)
• L04AC05 - USTEKINUMAB (WHO)

Reference brand drug: Stelara

 

External Links for Wezlana:

Search on Google

• Wezlana side effects
• Wezlana dosage
• ustekinumab side effects
• ustekinumab dosage